Akanda catches a cannabis craze wave

The weed rally came back with a vengeance

Akanda didn’t wake up with some magical company-specific breakthrough. Instead, it got dragged higher by the whole cannabis complex, which has been acting like it just found its old college playlist and remembered how to party.

The spark: U.S. regulators moved marijuana products into Schedule III, and now an expedited broader reclassification process is underway, with a new administrative hearing set for June 29. That’s the kind of policy headline that can light a match under the entire sector, especially the skinnier names that trade more on vibes than fundamentals.

Company news? Kinda, but not the main character

Akanda also said it adjourned its Special Meeting of Shareholders today because it didn’t have a quorum. On a normal day, that would be the headline. In cannabis-stock land, though, it was basically background noise.

The stock has already been living a chaotic life: Akanda recently did a 1-for-4.5 reverse split on April 13, which slashed its share count to roughly 534,400. So when speculative money starts chasing the sector, AKAN can move like a shopping cart with one bad wheel — fast, messy, and not exactly stable.

Why investors should care

At $25.17, the stock was up 43.91% at the time of publication, with momentum indicators screaming “beyond stretched.” That doesn’t mean the move is fake; it means the move is fragile. If the policy story keeps improving, names like AKAN can keep levitating. If the hype fades, gravity tends to show up very quickly.

Big picture: this is less about Akanda’s business update and more about how one policy headline can turn the entire cannabis sector into a momentum pinball machine.